{{current_slide_index}}/{{total_slide_count}} July 20232023Nanion launches AtlaZAtlaZ brings in vitro cell analytics to a new dimension. It is an advanced system designed for quantitative live-cell analysis. It provides researchers with the capability to investigate various cellular aspects label-free and in real time.July{{current_slide_index}}/{{total_slide_count}} Jan 20222022Nanion celebrates 20 years of innovationOver the course of 20 years, we have stayed true to our passion for continuous improvement and constant growth. We are still commited to providing the best possible support for our customers.January{{current_slide_index}}/{{total_slide_count}} July 20212021JulyLaunch of the SyncroPatch 384Newest generation automated patch clamp system has been introduced to the market. Whether you are screening large compound libraries or investigating complex biophysical properties of ion channels, the SyncroPatch can do it all due to its high flexibility. {{current_slide_index}}/{{total_slide_count}} June 20212021Introducing Orbit 16 TCThe Orbit 16 TC platform takes the pain out of bilayer painting, with 16 recording channels and temperature control. June{{current_slide_index}}/{{total_slide_count}} Sep 20192019Big expansion of Nanion´s product portfolioWe were very busy with the launch of three major additions to our product portfolio: FLEXcyte 96 for contractile force measurements, Dynamite8 for automated dynamic clamp recordings and Port-a-Patch mini for cost effective and fast patch clamping. We enjoyed showcasing them during the SPS meeting in Barcelona. September{{current_slide_index}}/{{total_slide_count}} Jun 20172017Nanion expands business to JapanNanion KK was founded in 2017 within the prestigious Tokyo Women´s Medical University - Waseda University Joint Institution for Advanced Biomedical Scieneces (TWins). June{{current_slide_index}}/{{total_slide_count}} Feb 20172017Launch of SURFE2R 96SEThe SURFE2R 96SE is the first instrument on the market featuring the solid supported membrane (SSM) technology for the robust and simple screening of membrane transporters and pumps in a high throughput manner. February{{current_slide_index}}/{{total_slide_count}} Jun 20162016Nanion opens site in DenmarkThe new fully equipped facility within Copenhagen University opened its doors for scientific collaborations, assay development support and product demonstrations.June{{current_slide_index}}/{{total_slide_count}} Sept 20142014Launch of CardioExcyte 96In 2014, we launched the CardioExcyte 96, equipped with contractility and field potential technology, to analyze iPSC-derived cardiomyocyte networks for drug safety assessment. It also enables cell monitoring for cell viability assays on a diverse range of cells types (e. g. hepatocytes) for toxicity screening. September{{current_slide_index}}/{{total_slide_count}} Sept 20142014"Deutscher Zukunftspreis" nomination and more product releasesNanion was one of 3 companies nominated for the prestigious prize for technology and innovation awarded by the German president. In the same year, Nanion launched the CardioExcyte 96 for contractility and electrophysiology recordings of cardiomyocytes and the Orbit mini for bilayer measurements.September{{current_slide_index}}/{{total_slide_count}} Sept 20142014Launch of Orbit miniOrbit 16 got a little brother! In 2014 we introduced the Orbit mini, a miniaturized bilayer workstation enabling the recording of 4 artificial lipid bilayers simultaneously.September{{current_slide_index}}/{{total_slide_count}} Sept 20132013APC meets HTS Nanion starts shipping its high throughput screening instrument, the SyncroPatch 384PE.September{{current_slide_index}}/{{total_slide_count}} Feb 2012 2012Membrane biophysics benefits The Orbit 16 for recording 16 bilayers in parallel was launched and Nanion acquired the SURFE²R Technology for Transporter Protein Analysis. February{{current_slide_index}}/{{total_slide_count}} July 2009
2009Winner of the “Deutscher Gründerpreis” and STEP AwardThe Deutscher Gründerpreis is the most prestigious award for outstanding entrepreneurs in Germany. In the same year, Nanion competed with 120 companies to be awarded the STEP Award 2009 and established Nanion Inc. in New Jersey, USA.July{{current_slide_index}}/{{total_slide_count}} Jan 2008
2008First "User publication" in Nature The first Patchliner user publication focus on TRC5 ion channel and its function in rheumatoid arthritis and it was published in high impact journal, Nature.January{{current_slide_index}}/{{total_slide_count}} Jun 2007
2007Vesicle Prep Pro launched Nanion launched the Vesicle Prep Pro for the quick and easy production of giant vesicles (GUVs).
2006Patchliner introduced into the market The Patchliner was the second patch clamp instrument launched by Nanion. It was the first fully automated patch clamp device from Nanion recording from multiple cells in parallel.July{{current_slide_index}}/{{total_slide_count}} May 2003
2003Nanion launches its first patch clamp instrument The Port-a-Patch, the world’s smallest patch clamp rig, was introduced onto the market in 2003. May{{current_slide_index}}/{{total_slide_count}} July 2002
2002Nanion was founded "In 2002, we published what I would consider to be my most important scientific work: the development and successful implementation of the planar patch clamp approach. This work was not only the most important of my scientific achievements, but also the basis for starting Nanion Technologies in the same year, with Michael George as CTO. " - Niels Fertig, CEO July20232002{{current_slide_index}} / {{total_slide_count}}
